- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Locally advanced, unresectable or metastatic adenocarcinoma of the pancreas
- Meeting Date: March 2014
- Public Summary Document (PSD) March 2014 PBAC Meeting - PDF
Paclitaxel-nanoparticle albumin bound – March 2014
Paclitaxel-Nanoparticle Albumin Bound, 100 mg injection, 1 x 100 mg vial, 250 mg injection, 1 x 250 mg vial, Abraxane®
Last updated
8 November 2023